Related Experiment Video
Updated: Jul 3, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
Fetuin-A Modulates Tumor Growth and Invasion in a Basal-like Triple Negative Breast Cancer Cell line, MDA-MB-468
Divya B Kenchappa1,2, Olga Korolkova1, Nobelle Sakwe3
1Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 Dr. D.B. Todd Blvd., Nashville, TN 37208.
Fetuin-A promotes triple-negative breast cancer (TNBC) growth and invasion by activating Toll-like receptor 4 (TLR4) signaling. Inhibiting TLR4 blocks these fetuin-A-mediated effects, suggesting a therapeutic target for TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Triple-negative breast cancer (TNBC) often has a poor prognosis.
- Fetuin-A is implicated in cancer progression, but its specific role in TNBC is not fully understood.
Purpose of the Study:
- To investigate the role of fetuin-A in the growth and invasion of MDA-MB-468, a TNBC cell line.
- To explore the involvement of fetuin-A-TLR4 signaling in TNBC progression.
Main Methods:
- Overexpression of fetuin-A in MDA-MB-468 cells.
- Assessment of cell invasion, adhesion, and growth.
- Evaluation of Toll-like receptor 4 (TLR4) expression.
- Inhibition of TLR4 using CLI-095 (resatorvid).
Main Results:
- Fetuin-A overexpression significantly enhanced MDA-MB-468 cell invasion.
- Fetuin-A increased TLR4 expression on TNBC cells.
- Inhibition of TLR4 abrogated fetuin-A-mediated growth and invasion.
Conclusions:
- Fetuin-A promotes TNBC growth and invasion through a signaling network involving TLR4.
- The fetuin-A-TLR4 axis represents a potential therapeutic target for TNBC.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020